Development -- Yang et al. 130 (23): 5569 Figure IG6

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. PP2A:B56 ${epsilon}$ is required for neural tube closure and formation of head structures. (A-C) Dorsal views of stage 16 embryos. (A) Control; (B) embryo injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino bilaterally; (C) embryo injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino and 20 pg of PP2A:B56 ${epsilon}$ -c mRNA bilaterally. (D-F) Anterior view of stage 16 embryos. (D) Control embryo; (E) embryo injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino bilaterally; (F) embryo injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino and 20 pg of PP2A:B56 ${epsilon}$ -c mRNA bilaterally. (G-I) Tadpole stage. (G) Control; (H) embryo was injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino; (C) embryo was injected with 2.5 ng of PP2A:B56 ${epsilon}$ morpholino and 20 pg of PP2A:B56 ${epsilon}$ -c mRNA.